GATACA, LLC

Biotech · Private

Machine learning software (GAT-ML) for reconstructing complete viral haplotypes and populations from next-generation sequencing data of hepatitis B virus quasispecies

Grants
$510K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Development of a tool for the whole genome de novo assembly of hepatitis B virus (HBV) populations$243,155
Federal grantDepartment of Health and Human Services · Phase I · Development of a joint machine learning/de novo assembly system for resolving viral quasispecies$267,225
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3226Quercus Molecular Design, LLC——
3227CELLGORTHMICS, INC——
3228ROCKLAND IMMUNOCHEMICALS, INC.——
3229GATACA, LLC——
3230KADVAX TECHNOLOGIES, INC.——
3231SONOVAL LLC——
3232ROSEBUD BIOSCIENCES INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 1
  • Integrated Desktop Software for Management of Virus Dataapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.